Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
European Vaccine Initiative (EVI)
What Does European Vaccine Initiative (EVI) Do?
The European Vaccine Initiative (EVI) is a non-profit product development partnership (PDP) dedicated to developing effective, accessible, and affordable vaccines against diseases of poverty and emerging infectious diseases. EVI works with a global network of partners from academia, public research institutions, and biotechnology companies to translate promising vaccine candidates from preclinical research through to clinical development, often up to Phase IIb proof-of-concept. Their key focus areas include malaria, diarrheal diseases, neglected tropical diseases, and emerging pandemic threats. EVI plays a crucial role in bridging the gap between basic research and late-stage vaccine development for diseases disproportionately affecting low- and middle-income countries.
Where Is European Vaccine Initiative (EVI)'s Headquarters?
HQ Function
Serves as the central hub for EVI's global operations, including scientific coordination, project management, fundraising, advocacy, financial administration, and partnership management for its vaccine development programs.
Notable Features:
Located within the Heidelberg University Hospital campus, providing close proximity to world-class research facilities and a vibrant biomedical ecosystem. This strategic positioning fosters collaborations with leading scientists and institutions.
Work Culture:
A mission-driven, collaborative, and international environment focused on scientific excellence, innovation, and addressing global health inequities. The culture emphasizes teamwork, agility, and a strong commitment to making a tangible impact on diseases affecting vulnerable populations.
HQ Significance:
The Heidelberg HQ is pivotal for orchestrating EVI's complex international projects, securing funding, and leveraging Germany's and Europe's strong biomedical research infrastructure to advance its vaccine pipeline.
Values Reflected in HQ: The choice of location within a leading academic and medical research hub underscores EVI's commitment to scientific rigor, innovation, collaboration, and translational research.
Location:
While headquartered in Germany with a country office in Uganda, EVI's operational footprint is global. It supports and manages vaccine development projects and clinical trials across numerous countries in Africa, Asia, and Europe. Its global presence is defined by its extensive network of academic partners, research institutions, contract research organizations (CROs), and public health bodies in both high-income and low- and middle-income countries. Functions supported globally include preclinical and clinical research management, technical expertise provision, capacity strengthening in trial sites, and engagement with global health stakeholders.
Street Address:
UniversitätsKlinikum Heidelberg, Im Neuenheimer Feld 326
City:
Heidelberg
State/Province:
Baden-Württemberg
Country:
Germany
Where Else Does European Vaccine Initiative (EVI) Operate Around the World?
Kampala, Uganda
Address: Plot 111 Owen Road, Mulago Hospital Complex, P.O. Box 7072, Kampala, Uganda (Note: Verify exact current address via official channels if critical)
Strengthens EVI's operational capabilities in Sub-Saharan Africa, enabling closer collaboration with African research institutions, healthcare providers, and communities. This is vital for conducting ethically sound and contextually relevant clinical trials and ensuring future vaccine uptake.
Buying Intent Signals for European Vaccine Initiative (EVI)
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Who's Leading European Vaccine Initiative (EVI)? Meet the Executive Team
As of April 2025, European Vaccine Initiative (EVI)' leadership includes:
Who's Investing in European Vaccine Initiative (EVI)?
European Vaccine Initiative (EVI) has been backed by several prominent investors over the years, including:
What Leadership Changes Has European Vaccine Initiative (EVI) Seen Recently?
Publicly available information regarding executive new hires or exits at the European Vaccine Initiative in the last 12 months is limited. Non-profit organizations like EVI tend to have stable leadership teams, and changes are typically announced on their official website or through targeted communications if deemed significant. No major changes have been prominently reported recently.
What Technology (Tech Stack) Is Used byEuropean Vaccine Initiative (EVI)?
Discover the tools European Vaccine Initiative (EVI) uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
European Vaccine Initiative (EVI) Email Formats and Examples
The European Vaccine Initiative typically uses the email format [first].[last]@evi.eu. This is a common professional email structure.
[first].[last]@evi.eu
Format
ole.olesen@evi.eu
Example
90%
Success rate
What's the Latest News About European Vaccine Initiative (EVI)?
evi.eu • May 13, 2024
European Vaccine Initiative and Partners Launch REACTOVAL Project to Advance mRNA Vaccine Technology for Pandemic Preparedness
EVI, as part of a consortium, has launched the REACTOVAL project, funded by Horizon Europe. The project aims to establish an agile platform for the rapid development and manufacturing of mRNA vaccines against emerging infectious diseases, enhancing Europe's pandemic response capabilities....more
evi.eu • February 26, 2024
European Vaccine Initiative Participates in Kick-off of TRANSVAC-DS Project
EVI is a partner in the newly launched TRANSVAC-DS project, funded by Horizon Europe. The project aims to design a sustainable research infrastructure for vaccine development in Europe, building on the success of previous TRANSVAC initiatives by providing services and training to advance vaccine R&D....more
evi.eu • November 27, 2023
EVI leads new EU-funded project PREVIPPI to advance novel schistosomiasis vaccine candidate
The European Vaccine Initiative (EVI) announced it is coordinating PREVIPPI, a new EU-funded project under Horizon Europe. PREVIPPI aims to advance the clinical development of a promising vaccine candidate (SmP29/Glucan) against schistosomiasis, a debilitating parasitic disease affecting millions globally....more
Highperformr's free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including European Vaccine Initiative (EVI), are just a search away.